GUJARAT THEMIS BIOSYN
Back to Balance Sheet
|
GUJARAT THEMIS BIOSYN Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹37 Cr | ₹36 Cr | ₹36 Cr | ₹32 Cr | ₹26 Cr |
What is the latest Total Current Liabilities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹37 Cr |
| Mar2024 | ₹36 Cr |
| Mar2023 | ₹36 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹26 Cr |
How is Total Current Liabilities of GUJARAT THEMIS BIOSYN Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹37 Cr | 2.93 | |
| Mar2024 | ₹36 Cr | 1.39 | |
| Mar2023 | ₹36 Cr | 12.71 | |
| Mar2022 | ₹32 Cr | 22.45 | |
| Mar2021 | ₹26 Cr | - | |
Compare Total Current Liabilities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹5,609.0 Cr | 4.6% | 22.1% | 12.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 4.6% |
22.1% |
12.4% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses